Future indications for terlipressin therapy
نویسندگان
چکیده
منابع مشابه
Hyponatraemia during terlipressin therapy.
http://gut.bmj.com/content/59/3/417.2.full.html Updated information and services can be found at: These include: References http://gut.bmj.com/content/59/3/417.2.full.html#ref-list-1 This article cites 8 articles, 2 of which can be accessed free at: service Email alerting box at the top right corner of the online article. Receive free email alerts when new articles cite this article. Sign up in...
متن کاملTerlipressin for Hepatorenal Syndrome: Novel Strategies and Future Perspectives
Type 1 hepatorenal syndrome (HRS) is a functional renal failure that often occurs in patients with cirrhosis and ascites. Type 1 HRS develops as the consequence of a severe reduction of effective circulating volume due to both extreme splanchnic arterial vasodilatation and reduction of cardiac output. Several pilot studies and two randomized control studies have shown that terlipressin plus alb...
متن کاملIndications for collapse therapy.
The indications for collapse therapy in the treatment of tuberculosis, simply stated, are—an active pulmonary lesion. Collapse therapy has come to the front as the most effective treatment of pulmonary tuberculosis and ahead of the older measures of rest, fresh air, diet, and climatic change. There is little difference of opinion about the effectiveness of collapse therapy as determined by clin...
متن کاملMeta-analysis: terlipressin therapy for the hepatorenal syndrome.
BACKGROUND The hepatorenal syndrome is a severe and well-known complication of end-stage liver disease, but its management is controversial. Recent reports have shown the efficacy of terlipressin therapy, a vasopressin analogue, in hepatorenal syndrome patients. AIM To evaluate the efficacy and safety of terlipressin in the treatment of hepatorenal syndrome. METHODS We performed a systemati...
متن کاملWake-up Stroke and Onset-to-door Duration Delays: Potential Future Indications for Reperfusion Therapy.
INTRODUCTION There is limited utilisation of acute stroke reperfusion treatments which have narrow therapeutic windows, with delayed hospital presentation being a major limiting factor in Singapore. Most patients who wake up with symptoms are ineligible for reperfusion treatments as duration from onset time is not known. We studied the profile of wake-up strokes, onset-to-door duration and thei...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Alimentary Pharmacology & Therapeutics
سال: 2004
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2004.02116.x